About
Basic Data Updated:
4 days ago"Introducing SEQUEL PHARMACEUTICALS (INDIA) PRIVATE LIMITED - a leading manufacturer of active pharmaceutical ingredients and bulk drugs. With a strong focus on quality and innovation, Sequel Pharmaceuticals Private Limited (SPI) has established itself as a trusted supplier in the pharmaceutical industry. Our impressive product portfolio includes telmisratan, ramipril, tamsolusin and lamotrigine, catering to the needs of esteemed clients such as Glenmark Pharmaceuticals Ltd and US Vitamins Ltd. In addition to our successful API business, we have also ventured into formulation manufacturing since 2011-12. Headquartered in Navi Mumbai, with a state-of-the-art manufacturing unit in Ambernath, Maharashtra, SPI has been serving the healthcare sector since its inception in 2006."
Industry
Company Details
- Location
Ambernath, Maharashtra, India
- Website12224421
- Telephone12224421
- Email Address12224421
- Social Media12224421
| CIN/LLPIN/FCRN | U24239MH2006PTC162896 |
| Company No. | 162896 |
| Company Classification | Private Limited Indian Non-Government Company |
| Incorporation Date | 28 Jun 2006 |
| Date of AGM | 30 Sep 2023 |
| Date of Balance Sheet | 31 Mar 2023 |
| Listing Status | Unlisted |
| ROC Code | Roc Mumbai |
Financials of Sequel Pharmaceuticals (India) Private Limited
Sequel Pharmaceuticals (India) Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 93.21% increase in profit. The company's net worth dipped by a decrease of 0.02%.
Corporate Structure
Unlock access to Sequel Pharmaceuticals (India)'s control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
People in Sequel Pharmaceuticals (India) Private Limited
Unlock and access historical data on people associated with Sequel Pharmaceuticals (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Board Members(2)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Nkgsb Co-Op. Bank Ltd. Creation Date: 07 Apr 2011 | ₹5.00 Cr | Open |
Corporation Bank Creation Date: 22 Dec 2007 | ₹29.31 Cr | Satisfied |
Janakalyan Sahakari Bank Ltd. Creation Date: 10 Aug 2007 | ₹4.18 Cr | Satisfied |
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sequel Pharmaceuticals (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sequel Pharmaceuticals (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alert
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Recent activity within the organization
Annual General Meeting
Sequel Pharmaceuticals (India) Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
30 Sep 2023Director Appointment
Nandadip Sakharam Rasam was appointed as a Director was appointed as a Director on 06 May 2023 & has been associated with this company since 1 year 12 days .
06 May 2023Balance Sheet
Sequel Pharmaceuticals (India) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Mumbai.
31 Mar 2023Director Appointment
Ramchandra Haridas Parade was appointed as a Director was appointed as a Director on 18 Jun 2020 & has been associated with this company since 3 years 10 months .
18 Jun 2020Charges
A charge registered on 10 Aug 2007 via Charge ID 10063597 with Janakalyan Sahakari Bank Ltd. was fully satisfied on 07 Jun 2017.
07 Jun 2017
Frequently asked questions
What is the Incorporation or founding date of Sequel Pharmaceuticals (India) Private Limited?
